HR 124 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023
To amend title XIX of the Social Security Act to provide incentives for education on the risk of renal medullary carcinoma in individuals who are receiving medical assistance under such title and who have sickle cell disease.
Summary
This bill amends Medicaid to add renal medullary carcinoma to the list of conditions for which states receive enhanced federal reimbursement when providing health education and risk awareness to Medicaid beneficiaries with sickle cell disease. Renal medullary carcinoma is a rare kidney cancer associated with sickle cell disease and trait. By including RMC alongside existing conditions like stroke, the bill creates a financial incentive for states to educate sickle cell disease patients about the risks of developing this cancer. The changes are effective upon enactment.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
- Rep. Green, Al [D-TX-9] (D-TX)
Money behind the sponsor
Top reported contributors to Al Green’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- GREATLAND LIVING $6,300
- NULL $6,000
- SOUTHERN NEWS GROUP $5,450
- Y&K REAL ESTATE $5,000
- TOKYO GARDENS CATERING $5,000
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Al Green → · Outside spending →
Actions (2)
- Jan 3, 2025 Referred to the House Committee on Energy and Commerce. · house
- Jan 3, 2025 Introduced in House
More bills on these subjects (8)
Other bills that carry the most legislative subjects in common with this one (topical discovery — distinct from the procedural related bills above).
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Full text
IN THE HOUSE OF REPRESENTATIVES
January 3, 2025
Mr. Green of Texas introduced the following bill; which was referred to the Committee on Energy and Commerce
A BILL
To amend title XIX of the Social Security Act to provide incentives for education on the risk of renal medullary carcinoma in individuals who are receiving medical assistance under such title and who have sickle cell disease.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Byron Nash Renal Medullary Carcinoma Awareness Act of 2023”.
SEC. 2. PROVIDING INCENTIVES FOR EDUCATION ON RISK OF RENAL MEDULLARY CARCINOMA TO INDIVIDUALS WITH SICKLE CELL DISEASE UNDER MEDICAID.
(a) In General.—Section 1903(a)(3)(E)(ii) of the Social Security Act (42 U.S.C. 1396b(a)(3)(E)(ii)) is amended by inserting “, renal medullary carcinoma,” after “stroke” each place it appears.
(b) Effective Date.—The amendments made by subsection (a) shall apply with respect to items and services furnished on or after the date of the enactment of this Act. <all>
Comments